Allogeneic UCB-derived CAR-T for SLE
Allogeneic UCB-derived CAR-T for SLE
Recruiting · NCT07274059 · Registry updated 2025-12-10Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Allogeneic UCB-derived CAR-T for SLE | Skin and Connective Tissue Diseases, autoimmune disease, connective tissue disorder, immune system disorder, systemic lupus erythematosus | Recruiting | Early phase 1 | 2025-12-10 | NCT07274059 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Chengdu Ucello Biotechnology Co., Ltd. | 5 |
| The General Hospital of Western Theater Command | 26 |
| Yancheng Third People's Hospital | 1 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| The General Hospital of Western Theater Command | Chengdu | China | 9 |
| Yancheng Third People's Hospital | Yancheng | China | 3 |